دورية أكاديمية
Yersinia pestis Pla Protein Thwarts T Cell Defense against Plague.
العنوان: | Yersinia pestis Pla Protein Thwarts T Cell Defense against Plague. |
---|---|
المؤلفون: | Smiley ST; Trudeau Institute, Saranac Lake, New York, USA., Szaba FM; Trudeau Institute, Saranac Lake, New York, USA., Kummer LW; Trudeau Institute, Saranac Lake, New York, USA., Duso DK; Trudeau Institute, Saranac Lake, New York, USA., Lin JS; Trudeau Institute, Saranac Lake, New York, USA jslin@trudeauinstitute.org. |
المصدر: | Infection and immunity [Infect Immun] 2019 Apr 23; Vol. 87 (5). Date of Electronic Publication: 2019 Apr 23 (Print Publication: 2019). |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5522 (Electronic) Linking ISSN: 00199567 NLM ISO Abbreviation: Infect Immun Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Washington, DC : American Society For Microbiology Original Publication: [Bethesda, Md.] American Society for Microbiology. |
مواضيع طبية MeSH: | Fibrinolysis/*immunology , Plague/*immunology , Plasminogen Activators/*immunology , T-Lymphocytes/*immunology , Virulence Factors/*immunology , Yersinia pestis/*pathogenicity, Animals ; Disease Models, Animal ; Humans ; Mice ; Mice, Inbred C57BL |
مستخلص: | Plague is a rapidly lethal human disease caused by the bacterium Yersinia pestis This study demonstrated that the Y. pestis plasminogen activator Pla, a protease that promotes fibrin degradation, thwarts T cell-mediated defense against fully virulent Y. pestis Introducing a single point mutation into the active site of Pla suffices to render fully virulent Y. pestis susceptible to primed T cells. Mechanistic studies revealed essential roles for fibrin during T cell-mediated defense against Pla-mutant Y. pestis Moreover, the efficacy of T cell-mediated protection against various Y. pestis strains displayed an inverse relationship with their levels of Pla activity. Together, these data indicate that Pla functions to thwart fibrin-dependent T cell-mediated defense against plague. Other important human bacterial pathogens, including staphylococci, streptococci, and borrelia, likewise produce virulence factors that promote fibrin degradation. The discovery that Y. pestis thwarts T cell defense by promoting fibrinolysis suggests novel therapeutic approaches to amplifying T cell responses against human pathogens. (Copyright © 2019 American Society for Microbiology.) |
References: | PLoS Negl Trop Dis. 2018 Jun 11;12(6):e0006511. (PMID: 29889829) Front Cell Infect Microbiol. 2013 Jul 26;3:35. (PMID: 23898467) Nat Rev Microbiol. 2003 Oct;1(1):55-64. (PMID: 15040180) J Immunol. 2011 Jul 15;187(2):897-904. (PMID: 21653834) Trends Microbiol. 2016 Mar;24(3):190-197. (PMID: 26698952) Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5526-30. (PMID: 16567636) J Med Microbiol. 1996 Dec;45(6):440-4. (PMID: 8958247) Annu Rev Microbiol. 2005;59:69-89. (PMID: 15847602) Adv Exp Med Biol. 2012;954:253-60. (PMID: 22782771) Cell. 2015 Oct 8;163(2):354-66. (PMID: 26451485) Vaccine. 2011 Sep 2;29(38):6572-83. (PMID: 21763383) Infect Immun. 2005 Jul;73(7):3888-95. (PMID: 15972474) Crit Rev Microbiol. 2016 Nov;42(6):866-82. (PMID: 26485450) Immunol Rev. 2008 Oct;225:256-71. (PMID: 18837787) J Thromb Haemost. 2012 Dec;10(12):2555-62. (PMID: 23083123) Curr Opin Microbiol. 2006 Feb;9(1):55-61. (PMID: 16413818) Am J Pathol. 2005 May;166(5):1427-39. (PMID: 15855643) Infect Immun. 1998 Dec;66(12):5755-62. (PMID: 9826351) Thromb Haemost. 2005 Apr;93(4):627-30. (PMID: 15841305) Genes Dev. 1995 Aug 15;9(16):2020-33. (PMID: 7649481) Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91. (PMID: 16306265) Semin Thromb Hemost. 2006 Feb;32(1):5-10. (PMID: 16479457) Expert Rev Vaccines. 2008 Mar;7(2):209-21. (PMID: 18324890) J Clin Invest. 1998 Feb 1;101(3):560-9. (PMID: 9449688) Thromb Haemost. 2007 Sep;98(3):512-20. (PMID: 17849039) Bull World Health Organ. 1970;42(5):653-66. (PMID: 4988692) Emerg Microbes Infect. 2014 Dec;3(12):e86. (PMID: 26038506) Vaccine. 2002 May 22;20(17-18):2206-14. (PMID: 12009274) J Thromb Haemost. 2007 Jul;5 Suppl 1:24-31. (PMID: 17635705) J Immunol. 2001 Sep 1;167(5):2887-94. (PMID: 11509636) Science. 2007 Jan 26;315(5811):509-13. (PMID: 17255510) Thromb Haemost. 1997 Jan;77(1):1-10. (PMID: 9031440) Infect Immun. 2012 Jan;80(1):206-14. (PMID: 22064714) Infect Immun. 2005 Nov;73(11):7304-10. (PMID: 16239527) JAMA. 2000 May 3;283(17):2281-90. (PMID: 10807389) Emerg Microbes Infect. 2012 Nov;1(11):e36. (PMID: 26038406) J Immunol. 2011 Aug 15;187(4):1866-76. (PMID: 21724997) Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1044-8. (PMID: 1671533) J Thromb Haemost. 2009 Jan;7(1):4-13. (PMID: 19017261) J Thromb Haemost. 2005 Aug;3(8):1894-904. (PMID: 16102057) Exp Biol Med (Maywood). 2004 Dec;229(11):1105-10. (PMID: 15564436) Infect Immun. 2007 Feb;75(2):697-705. (PMID: 17101642) Blood. 2000 Oct 1;96(7):2329-37. (PMID: 11001879) Science. 1992 Nov 6;258(5084):1004-7. (PMID: 1439793) J Thromb Haemost. 2006 Jul;4(7):1580-7. (PMID: 16839357) Trends Cardiovasc Med. 2002 Apr;12(3):101-8. (PMID: 12007734) Infect Immun. 2009 Oct;77(10):4295-304. (PMID: 19620344) J Cell Biol. 2002 Aug 5;158(3):401-8. (PMID: 12163464) J Thromb Haemost. 2011 Jul;9 Suppl 1:182-8. (PMID: 21781254) Microb Pathog. 1997 Oct;23(4):211-23. (PMID: 9344782) PLoS Pathog. 2014 May 22;10(5):e1004142. (PMID: 24854422) Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8. (PMID: 10570195) Clin Microbiol Rev. 1997 Jan;10(1):35-66. (PMID: 8993858) Blood. 2009 Feb 5;113(6):1358-64. (PMID: 19056689) J Exp Med. 2003 Mar 17;197(6):801-6. (PMID: 12629066) Front Immunol. 2016 Dec 14;7:602. (PMID: 28018363) Semin Thromb Hemost. 2013 Jun;39(4):452-8. (PMID: 23539415) EMBO J. 1996 Nov 1;15(21):5760-71. (PMID: 8918453) J Clin Invest. 2004 Jun;113(11):1596-606. (PMID: 15173886) J Immunol. 2011 Feb 1;186(3):1675-84. (PMID: 21172869) J Immunol. 2013 Apr 15;190(8):4149-61. (PMID: 23487423) |
معلومات مُعتمدة: | R01 AI061577 United States AI NIAID NIH HHS; R01 AI071295 United States AI NIAID NIH HHS |
فهرسة مساهمة: | Keywords: Pla; T cell-mediated protection; Yersinia pestis; YopE; fibrin; fibrin degradation; fibrinolysis; immunization; plague; plasminogen activator |
المشرفين على المادة: | 0 (Virulence Factors) EC 3.4.21.- (Plasminogen Activators) |
تواريخ الأحداث: | Date Created: 20190227 Date Completed: 20190916 Latest Revision: 20200309 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC6479024 |
DOI: | 10.1128/IAI.00126-19 |
PMID: | 30804102 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1098-5522 |
---|---|
DOI: | 10.1128/IAI.00126-19 |